Login

Simone Veglioni discusses VANTEA SMART while EGOMNIA S.p.A. details strengths and projects in an online IPO talk. 00:10:00

Share On Facebook Share On Twitter

Simone Veglioni ceo of Vantea SMART S.p.A

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Former CEO Christer Fehrling introduces new ceo David Rytter | David Rytter, CEO, Avtech Sweden AB (publ) AVT B:STO
00:10:00
Turbocharge Retirement Savings with Cash Balance Plans
00:10:00
Yuval Levin on Edmund Burke, Thomas Paine, and the Roots of Political Ideology
00:10:00
Permira's Strategic Insights and Future Directions: A Conversation with Kurt Bjorklund | Kurt Bjorklund, Co-Managing Partner, Permira.
00:10:00
Jon Gilligan of Liberty Gold Corp. and Joe Mazumdar of Exploration Insights discuss open-pit oxide gold deposits in the prolific Great Basin region, focusing on flagship projects Black Pine and Goldstrike at Metals Investor Forum.|Jon Gilligan, President
00:10:00
Paul Ryan on Health Care Reform and the Flaws of Obamacare
00:10:00
CleanTech Lithium Eyes ASX Listing and $20M Raise to Advance Sustainable Lithium Project in Chile
00:10:00
Listen, strategize, and support our partners as we pursue our shared goals.|Jeffrey Ansell, Strategic Executive Advisor,Vestar Capital Partners
00:10:00
Jesse Fink: A Journey of Impact and Philanthropy in Action at MissionPoint Capital Partners
00:10:00
Understanding Financial Complexity: Kara Beth Vance Explains Timothy Financial Counsel’s Simple Levels Approach | Kara Beth, Principal , Timothy Financial Counsel.
00:10:00
Market Recap and Enduring Investment Principles
00:10:00
Ceapro's patented process technologies include Pressurized Gas eXpanded technology|Gilles Gagnon,President,Ceapro Inc

© 2017 - Neuhu+